Atex upgrade allows News to decommission mainframes, build on integration

Nov 08, 2011 at 06:33 pm by Staff


Atex has announced that it has signed News Limited – the Australian publishing business of News Corporation – for a 2700-seat upgrade as part of its plans for a single national advertising system.

The “next phase” of what Atex says is a major project will see News’ previous generation Atex advertising system upgraded and integrated with an existing 800 seat Atex system. This will enable two mainframe-based systems which are approaching the end of their life to be decommissioned over a nine-month timeframe.

Licensed for up to 2700 users, the system will support News’ entire Australia-wide advertising business across more than 120 publications. Five major metro newspapers include Australia's largest circulation daily, the Melbourne ‘Herald-Sun’. 

Director sales and publishing systems Gary McKenzie says having one system to support all of its advertising sales, “regardless of location across Australia, for all ad types and styles” was important for News.

“We will take advantage of the advertising workflow tool and add more user tools via integration,” he says.

News advertising sales systems business manager John Williamson explained to GXpress that using Atex Cyber$ell as a ‘pass-through’ from existing CyberAd systems to the group’s new financial system will allow the mainframes to be decommissioned.

“This means that our sales agents who currently use CyberAd will still continue to use this application but the back-end processing will change,” he says. “Previously, our CyberAd bookings went to our financial system via our mainframe application.

“What this potentially enables us to do now that we have the bookings in our national Cyber$ell application is to integrate our other national tools, such as the new layout process we are developing with Advanced Publishing Systems.”

• See News/APS integration brings an end to 'sad ads'


Comments

or Register to post a comment




ADVERTISEMENTS


ADVERTISEMENTS